Financials ICL Group Ltd

Equities

ICL

IL0002810146

Agricultural Chemicals

Market Closed - TEL AVIV STOCK EXCHANGE 07:24:08 2024-04-25 am EDT 5-day change 1st Jan Change
1,747 ILa -1.02% Intraday chart for ICL Group Ltd -1.19% -3.91%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 6,031 6,519 12,439 9,330 6,489 5,921 - -
Enterprise Value (EV) 1 8,441 8,982 14,888 11,413 8,584 7,776 7,584 7,494
P/E ratio 12.7 x 509 x 16.1 x 4.34 x 10.1 x 13.3 x 10.1 x 9.7 x
Yield 4.67% 1.97% 3.21% 12.6% 5.36% 4.05% 4.94% 5.16%
Capitalization / Revenue 1.14 x 1.29 x 1.79 x 0.93 x 0.86 x 0.84 x 0.8 x 0.8 x
EV / Revenue 1.6 x 1.78 x 2.14 x 1.14 x 1.14 x 1.1 x 1.02 x 1.01 x
EV / EBITDA 7.05 x 9.07 x 9.07 x 2.85 x 4.89 x 5.58 x 4.69 x 4.35 x
EV / FCF 18.1 x 40.6 x 32.8 x 8.68 x 10.5 x 26.5 x 16.1 x 14.4 x
FCF Yield 5.53% 2.46% 3.05% 11.5% 9.49% 3.77% 6.21% 6.97%
Price to Book 1.54 x 1.66 x 2.75 x 1.71 x 1.13 x 0.99 x 0.94 x 0.9 x
Nbr of stocks (in thousands) 1,280,351 1,280,551 1,287,151 1,287,151 1,289,256 1,289,565 - -
Reference price 2 4.710 5.091 9.664 7.248 5.033 4.591 4.591 4.591
Announcement Date 2/13/20 2/11/21 2/9/22 2/15/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,271 5,043 6,955 10,015 7,536 7,038 7,420 7,398
EBITDA 1 1,198 990 1,642 4,007 1,754 1,394 1,616 1,722
EBIT 1 760 509 1,194 3,509 1,218 856.8 1,058 1,178
Operating Margin 14.42% 10.09% 17.17% 35.04% 16.16% 12.17% 14.25% 15.92%
Earnings before Tax (EBT) 1 628 49 1,092 3,404 974 688.4 860.5 908.8
Net income 1 475 11 783 2,159 647 446.1 586.5 611
Net margin 9.01% 0.22% 11.26% 21.56% 8.59% 6.34% 7.9% 8.26%
EPS 2 0.3700 0.0100 0.6000 1.670 0.5000 0.3445 0.4538 0.4734
Free Cash Flow 1 467 221 454 1,315 815 293.5 471 522
FCF margin 8.86% 4.38% 6.53% 13.13% 10.81% 4.17% 6.35% 7.06%
FCF Conversion (EBITDA) 38.98% 22.32% 27.65% 32.82% 46.47% 21.06% 29.14% 30.31%
FCF Conversion (Net income) 98.32% 2,009.09% 57.98% 60.91% 125.97% 65.79% 80.3% 85.43%
Dividend per Share 2 0.2200 0.1005 0.3100 0.9100 0.2700 0.1860 0.2270 0.2367
Announcement Date 2/13/20 2/11/21 2/9/22 2/15/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,790 2,038 2,525 2,880 2,519 2,091 - - - 1,690 1,773 1,726 1,939 1,779 -
EBITDA 1 421 575 1,002 1,258 1,049 698 610 - 346 357 347.3 346 355.6 368.9 -
EBIT 1 315 458 - 1,139 928 562 - - - 211 207.5 212.1 213.6 202.7 -
Operating Margin 17.6% 22.47% - 39.55% 36.84% 26.88% - - - 12.49% 11.71% 12.29% 11.02% 11.4% -
Earnings before Tax (EBT) 1 - - - - - - - - - 117 190.6 224.1 241.1 - -
Net income 1 225 283 - 563 633 331 280 163 137 67 98.27 101 120.6 124.8 -
Net margin 12.57% 13.89% - 19.55% 25.13% 15.83% - - - 3.96% 5.54% 5.85% 6.22% 7.01% -
EPS 2 0.1700 0.2100 - 0.4400 0.4900 0.2500 0.2200 0.1300 0.1100 0.0500 0.0761 0.0782 0.0934 0.0967 -
Dividend per Share 2 0.0800 0.1300 0.2400 0.2918 0.2435 0.1400 - - - 0.0500 0.0408 0.0478 0.0576 0.0572 -
Announcement Date 11/4/21 2/9/22 5/11/22 7/27/22 11/9/22 2/15/23 5/10/23 8/9/23 11/8/23 2/28/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,410 2,463 2,449 2,083 2,095 1,855 1,663 1,573
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.012 x 2.488 x 1.491 x 0.5198 x 1.194 x 1.331 x 1.029 x 0.9133 x
Free Cash Flow 1 467 221 454 1,315 815 294 471 522
ROE (net income / shareholders' equity) 12.4% 6.57% 18.5% 43.2% 11.5% 7.41% 10.6% 10.6%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 3.070 3.070 3.520 4.240 4.470 4.650 4.880 5.110
Cash Flow per Share 2 0.7700 0.6300 0.8300 1.570 1.240 0.9100 0.8600 -
Capex 1 576 626 611 747 780 815 750 750
Capex / Sales 10.93% 12.41% 8.79% 7.46% 10.35% 11.58% 10.11% 10.14%
Announcement Date 2/13/20 2/11/21 2/9/22 2/15/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
4.591 USD
Average target price
5.48 USD
Spread / Average Target
+19.35%
Consensus
  1. Stock Market
  2. Equities
  3. ICL Stock
  4. Financials ICL Group Ltd